🇺🇸 triple attack therapy in United States

triple attack therapy (triple attack therapy) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

triple attack therapy in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is triple attack therapy approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for triple attack therapy in United States?

Kasr El Aini Hospital is the originator. The local marketing authorisation holder may differ — check the official source linked above.